PURPLE BIOTECH LTD's ticker is PPBT and the CUSIP is 74638P109. A total of 17 filers reported holding PURPLE BIOTECH LTD in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,222 | -72.8% | 1,867 | -59.1% | 0.00% | – |
| Q1 2023 | $8,173 | -28.6% | 4,566 | -44.9% | 0.00% | – |
| Q4 2022 | $11,439 | -45.5% | 8,289 | -21.3% | 0.00% | – |
| Q3 2022 | $21,000 | +90.9% | 10,528 | +125.9% | 0.00% | – |
| Q2 2022 | $11,000 | +37.5% | 4,660 | +132.8% | 0.00% | – |
| Q1 2022 | $8,000 | -33.3% | 2,002 | -34.7% | 0.00% | – |
| Q4 2021 | $12,000 | -36.8% | 3,068 | -24.8% | 0.00% | – |
| Q3 2021 | $19,000 | -81.7% | 4,079 | -80.7% | 0.00% | – |
| Q2 2021 | $104,000 | +38.7% | 21,169 | +16.5% | 0.00% | – |
| Q1 2021 | $75,000 | -5.1% | 18,175 | -12.1% | 0.00% | – |
| Q4 2020 | $79,000 | – | 20,687 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 346,197 | $1,319,000 | 0.01% |
| Virtu Financial LLC | 22,988 | $88,000 | 0.01% |
| WASHINGTON TRUST BANK | 16,454 | $63,000 | 0.01% |
| TRUE Private Wealth Advisors | 6,700 | $25,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 28,800 | $110,000 | 0.00% |
| Your Advocates Ltd., LLP | 400 | $2,000 | 0.00% |
| Renaissance Technologies | 128,900 | $491,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| North Star Investment Management Corp. | 300 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 26,167 | $100,000 | 0.00% |